These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7739630)

  • 21. [Mechanism of translocation between chromosomes 4q and 10q in facioscapulohumeral muscular dystrophy].
    Wang N; Wu ZY; Wang CD; Wang ZQ; Lin MT; Fang L; Murong SX
    Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(8):650-3. PubMed ID: 12887821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two cases of chromosome 4q35-linked early onset facioscapulohumeral muscular dystrophy with mental retardation and epilepsy.
    Miura K; Kumagai T; Matsumoto A; Iriyama E; Watanabe K; Goto K; Arahata K
    Neuropediatrics; 1998 Oct; 29(5):239-41. PubMed ID: 9810558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical variability of facioscapulohumeral muscular dystrophy in Russia.
    Kazakov VM; Rudenko DI
    Muscle Nerve Suppl; 1995; 2():S85-95. PubMed ID: 7739632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fish mapping of 250 cosmid and 26 YAC clones to chromosome 4 with special emphasis on the FSHD region at 4q35.
    Wijmenga C; Dauwerse HG; Padberg GW; Meyer N; Murray JC; Mills K; van Ommen GB; Hofker MH; Frants RR
    Muscle Nerve Suppl; 1995; 2():S14-8. PubMed ID: 7739620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning and mapping of a very short (10-kb) EcoRI fragment associated with facioscapulohumeral muscular dystrophy (FSHD).
    Lee JH; Goto K; Sahashi K; Nonaka I; Matsuda C; Arahata K
    Muscle Nerve Suppl; 1995; 2():S27-31. PubMed ID: 7739622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion.
    Krasnianski M; Eger K; Neudecker S; Jakubiczka S; Zierz S
    Arch Neurol; 2003 Oct; 60(10):1421-5. PubMed ID: 14568813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neovascular glaucoma from advanced Coats disease as the initial manifestation of facioscapulohumeral dystrophy in a 2-year-old child.
    Shields CL; Zahler J; Falk N; Furuta M; Eagle RC; Espinosa LE; Fischer PR; Shields JA
    Arch Ophthalmol; 2007 Jun; 125(6):840-2. PubMed ID: 17563001
    [No Abstract]   [Full Text] [Related]  

  • 28. [Facioscapulohumeral muscular dystrophy (FSHD)].
    Funakoshi M; Goto K; Kim BY; Arahata K
    Nihon Rinsho; 1997 Dec; 55(12):3181-5. PubMed ID: 9436432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facioscapulohumeral muscular dystrophy in early childhood.
    Brouwer OF; Padberg GW; Wijmenga C; Frants RR
    Arch Neurol; 1994 Apr; 51(4):387-94. PubMed ID: 8155016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinal microvascular abnormalities and age-related hearing loss: the Blue Mountains hearing study.
    Liew G; Wong TY; Mitchell P; Newall P; Smith W; Wang JJ
    Ear Hear; 2007 Jun; 28(3):394-401. PubMed ID: 17485988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facioscapulohumeral dystrophy associated with mental retardation, hearing loss, and tortuosity of retinal arterioles.
    Matsuzaka T; Sakuragawa N; Terasawa K; Kuwabara H
    J Child Neurol; 1986 Jul; 1(3):218-23. PubMed ID: 3598127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of facial hypotonia and diagnosis of facioscapulohumeral dystrophy.
    Sheth VS; Shapiro MJ
    Arch Ophthalmol; 2008 May; 126(5):745-6; author reply 746. PubMed ID: 18474804
    [No Abstract]   [Full Text] [Related]  

  • 33. Coats-like retinopathy in an infant with preclinical facioscapulohumeral dystrophy.
    Ganesh A; Kaliki S; Shields CL
    J AAPOS; 2012 Apr; 16(2):204-6. PubMed ID: 22525183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facioscapulohumeral dystrophy associated with hearing loss and Coats syndrome.
    Taylor DA; Carroll JE; Smith ME; Johnson MO; Johnston GP; Brooke MH
    Ann Neurol; 1982 Oct; 12(4):395-8. PubMed ID: 7149664
    [No Abstract]   [Full Text] [Related]  

  • 35. FSHD-like patients without 4q35 deletion.
    Yamanaka G; Goto K; Ishihara T; Oya Y; Miyajima T; Hoshika A; Nishino I; Hayashi YK
    J Neurol Sci; 2004 Apr; 219(1-2):89-93. PubMed ID: 15050443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inner ear deafness in dystrophia myotonica and progressive muscular dystrophy].
    Kuhn E; Ey W
    Dtsch Med Wochenschr; 1966 May; 91(20):947-51. PubMed ID: 5930205
    [No Abstract]   [Full Text] [Related]  

  • 37. Facioscapulohumeral dystrophy, retinal vasculature, and Sneddon's syndrome.
    Coleman RJ; Ingram DA; Swash M
    Muscle Nerve; 1990 Aug; 13(8):759. PubMed ID: 2385262
    [No Abstract]   [Full Text] [Related]  

  • 38. Monozygotic twins with facioscapulohumeral dystrophy (FSHD): implications for genotype/phenotype correlation. FSH-DY Group.
    Griggs RC; Tawil R; McDermott M; Forrester J; Figlewicz D; Weiffenbach B
    Muscle Nerve Suppl; 1995; 2():S50-5. PubMed ID: 7739626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinal telangiectasis in facioscapulohumeral muscular dystrophy with deafness.
    Gurwin EB; Fitzsimons RB; Sehmi KS; Bird AC
    Arch Ophthalmol; 1985 Nov; 103(11):1695-700. PubMed ID: 4062636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group.
    Tawil R; Forrester J; Griggs RC; Mendell J; Kissel J; McDermott M; King W; Weiffenbach B; Figlewicz D
    Ann Neurol; 1996 Jun; 39(6):744-8. PubMed ID: 8651646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.